• Japanese
  • Korean
  • Chinese
Cover Image

Orthopedic Biomaterials | US | 2015 | Market Analysis

Notes

Despite recent obstacles, such as product approval denials, changes to treatment recommendations and a challenging economic environment, ongoing adoption of these products continues and overall interest in the use of these products remains high.

Despite recent and ongoing obstacles to growth, such as changes to treatment recommendations, challenging reimbursement environments, and negative publicity surrounding significant products, the US market for orthopedic biomaterials will show sustained and improving growth comparable to other large orthopedic markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic biomaterials in the US across a 10-year period.

Questions Answered in This Report:

  • In 2014, growth of BGS revenue in the spinal fusion segment continued to be hampered by declining use of Medtronic's INFUSE growth factor product.
    • Within spinal fusion procedures, which material segments will benefit from declining utilization of growth factor products
    • How will growth of the overall BGS market be impacted by ongoing hindrance of its largest revenue procedure segment
  • The FDA recently granted approval to Wright Medical Technology's Augment Bone Graft product for use in certain extremity procedures.
    • How will the launch of this product impact revenue growth in the extremity surgery space over the forecast period
    • What other key products are expected to gain FDA approval over the forecast period
  • In mid-2013, AAOS issued revised treatment guidelines for osteoarthritis of the knee recommending against the use of HA viscosupplementation.
    • How will this set of guidelines impact treatment volume growth in the US HA viscosupplementation market
    • How will market revenue for non-knee applications of HA viscosupplementation growth over the forecast period
  • The ongoing adoption of nonbone IBDs will negatively impact the use of machined bone IBDs, and thus revenue growth in this market.
    • What factors will drive the uptake of nonbone IBDs through 2023
    • For which approaches are machined bone IBDs likely to see significant growth or decline
  • Despite a lack of consensus in the clinical data surrounding cell concentration systems, procedure volumes will continue to show moderate growth.
    • Which orthopedic procedure segments generate the highest proportion of cell concentration system unit sales
    • What strategies are competitors of varying sizes using to expand product penetration and market share in this market

Scope:

Geographies Covered: US.

Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group uses its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2013-2023).

Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

VERSION HISTORY

1. ORTHOPEDIC BIOMATERIAL MARKET

  • 1.1. Market Snapshot
  • 1.2. Detailed Market Analysis
  • 1.3. Competitive Snapshot
  • 1.4. Market Shares
  • 1.5. Trends and Developments

2. BONE GRAFT SUBSTITUTE MARKET

  • 2.1. Market Snapshot
  • 2.2. Detailed Market Analysis
    • 2.2.1. By Material
      • 2.2.1.1. Autografts (Procedures Only)
      • 2.2.1.2. Growth Factors
      • 2.2.1.3. Demineralized Bone Matrices
      • 2.2.1.4. Orthopedic Stem Cell Products
      • 2.2.1.5. Nonproprietary Allografts
      • 2.2.1.6. First- and Second-Generation Synthetics
    • 2.2.2. By Procedure Type
      • 2.2.2.1. Spinal Fusion
        • 2.2.2.1.1. By Approach
        • 2.2.2.1.2. By Anatomy
          • 2.2.2.1.2.1. Thoracolumbar
          • 2.2.2.1.2.2. Cervical
      • 2.2.2.2. Trauma Surgery
      • 2.2.2.3. Large-Joint Revision and Reconstruction
      • 2.2.2.4. Extremity Surgery
      • 2.2.2.5. Craniomaxillofacial Surgery
  • 2.3. Competitive Snapshot
  • 2.4. Detailed Competitive Landscape
  • 2.5. Market Shares

3. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 3.1. Market Snapshot
  • 3.2. Detailed Market Analysis
    • 3.2.1. By Number of Injections
    • 3.2.2. By Anatomy
    • 3.2.3. By Facility Type (Qualitative Only)
  • 3.3. Competitive Snapshot
  • 3.4. Detailed Competitive Landscape
  • 3.5. Market Shares

4. MACHINED BONE INTERBODY DEVICE MARKET

  • 4.1. Market Snapshot
  • 4.2. Detailed Market Analysis
  • 4.3. Competitive Snapshot
  • 4.4. Detailed Competitive Landscape
  • 4.5. Market Shares

5. CELL CONCENTRATION SYSTEM MARKET

  • 5.1. Market Snapshot
  • 5.2. Detailed Market Analysis
  • 5.3. Competitive Snapshot
  • 5.4. Detailed Competitive Landscape
  • 5.5. Market Shares

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

APPENDIX: BIBLIOGRAPHY

LIST OF FIGURES AND TABLES

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

  • Figure 1: Orthopedic Biomaterial Market, by Product Type, US (USD), 2013-2023
  • Table 1: Orthopedic Biomaterial Market Landscape, US (USD), 2014 and 2023
  • Table 2: Orthopedic Biomaterial Revenue Market Share Rankings, by Product Type, US, 2014
  • Table 3: Companies Mentioned
  • Table 4: Factors Impacting the Orthopedic Biomaterial Market, by Product Type, US
  • Table 5: Recent Events in the Orthopedic Biomaterial Market, US
  • Table 6: Emerging Products for the Orthopedic Biomaterial Market, US
  • Table 7: Key Report Updates
  • Table 8: Orthopedic Biomaterial Procedures Covered, US
  • Table 9: Orthopedic Biomaterial Products Covered, US

VERSION HISTORY

  • Table 10: Version History

1. ORTHOPEDIC BIOMATERIAL MARKET

  • Figure 2: Orthopedic Biomaterial Market, by Product Type, US (USD), 2013-2023
  • Table 11: Orthopedic Biomaterial Market, by Product Type, US (USD), 2013-2023
  • Figure 3: Orthopedic Biomaterial Revenue Market Shares, US, 2014
  • Table 12: Orthopedic Biomaterial Revenue Market Shares, by Product Type, US, 2014
  • Table 13: Factors Impacting the Orthopedic Biomaterial Market, by Product Type, US
  • Table 14: Recent Events in the Orthopedic Biomaterial Market, US
  • Table 15: Emerging Products for the Orthopedic Biomaterial Market, US

2. BONE GRAFT SUBSTITUTE MARKET

  • Figure 4: BGS Market, by Material, US (USD), 2013-2023
  • Table 16: Bone Graft Units Used, by Material, US, 2013-2023
  • Table 17: BGS Market, by Material, US (USD), 2013-2023
  • Table 18: Growth Factor ASPs, by Package Volume, US (USD), 2014
  • Table 19: DBM ASPs, by Package Volume, US (USD), 2014
  • Table 20: Orthopedic Stem Cell Product ASPs, by Package Volume, US (USD), 2014
  • Table 21: Nonproprietary Allograft ASPs, by Package Volume, US (USD), 2014
  • Table 22: First-Generation Synthetic ASPs, by Package Volume, US (USD), 2014
  • Table 23: Second-Generation Synthetic ASPs, by Package Volume, US (USD), 2014
  • Table 24: Bone Graft Procedures, by Procedure Type, US, 2013-2023
  • Table 25: Average Volume of Bone Graft per Procedure, by Procedure Type, US, 2013
  • Table 26: BGS Market, by Procedure Type, US (USD), 2013-2023
  • Table 27: Spinal Fusion Bone Graft Units Used, by Material, US, 2013-2023
  • Table 28: Spinal Fusion BGS Market, by Material, US (USD), 2013-2023
  • Table 29: Spinal Fusion BGS Market, by Approach, US (USD), 2013-2023
  • Table 30: Spinal Fusion BGS Market Growth, by Approach, US, 2014-2023
  • Table 31: Posterolateral Fusion Bone Graft Units Used, by Material, US, 2013-2023
  • Table 32: Posterolateral Fusion BGS Market, by Material, US (USD), 2013-2023
  • Table 33: Posterolateral Fusion BGS Market Growth, by Material, US, 2014-2023
  • Table 34: Interbody Fusion Bone Graft Units Used, by Material, US, 2013-2023
  • Table 35: Interbody Fusion BGS Market, by Material, US (USD), 2013-2023
  • Table 36: Interbody Fusion BGS Market Growth, by Material, US, 2014-2023
  • Table 37: Spinal Fusion Bone Graft Procedures, by Anatomy, US, 2013-2023
  • Table 38: Thoracolumbar Fusion Bone Graft Procedures, by Scope, US, 2013-2023
  • Table 39: Thoracolumbar Fusion Bone Graft Units Used, by Material, US, 2013-2023
  • Table 40: Thoracolumbar Fusion BGS Market, by Material, US (USD), 2013-2023
  • Table 41: Thoracolumbar Fusion BGS Market Growth, by Material, US, 2014-2023
  • Table 42: One-Level Thoracolumbar Fusion Bone Graft Units Used, by Material, US, 2013-2023
  • Table 43: One-Level Thoracolumbar Fusion BGS Market, by Material, US (USD), 2013-2023
  • Table 44: One-Level Thoracolumbar Fusion BGS Market Growth, by Material, US, 2014-2023
  • Table 45: Two-Level Thoracolumbar Fusion Bone Graft Units Used, by Material, US, 2013-2023
  • Table 46: Two-Level Thoracolumbar Fusion BGS Market, by Material, US (USD), 2013-2023
  • Table 47: Two-Level Thoracolumbar Fusion BGS Market Growth, by Material, US, 2014-2023
  • Table 48: Multilevel Thoracolumbar Fusion Bone Graft Units Used, by Material, US, 2013-2023
  • Table 49: Multilevel Thoracolumbar Fusion BGS Market, by Material, US (USD), 2013-2023
  • Table 50: Multilevel Thoracolumbar Fusion BGS Market Growth, by Material, US, 2014-2023
  • Table 51: Cervical Fusion Bone Graft Procedures, by Scope, US, 2013-2023
  • Table 52: Cervical Fusion Bone Graft Units Used, by Material, US, 2013-2023
  • Table 53: Cervical Fusion BGS Market, by Material, US (USD), 2013-2023
  • Table 54: Cervical Fusion BGS Market Growth, by Material, US, 2014-2023
  • Table 55: One-Level Cervical Fusion Bone Graft Units Used, by Material, US, 2013-2023
  • Table 56: One-Level Cervical Fusion BGS Market, by Material, US (USD), 2013-2023
  • Table 57: One-Level Cervical Fusion BGS Market Growth, by Material, US, 2014-2023
  • Table 58: Two-Level Cervical Fusion Bone Graft Units Used, by Material, US, 2013-2023
  • Table 59: Two-Level Cervical Fusion BGS Market, by Material, US (USD), 2013-2023
  • Table 60: Two-Level Cervical Fusion BGS Market Growth, by Material, US, 2014-2023
  • Table 61: Multilevel Cervical Fusion Bone Graft Units Used, by Material, US, 2013-2023
  • Table 62: Multilevel Cervical Fusion BGS Market, by Material, US (USD), 2013-2023
  • Table 63: Multilevel Cervical Fusion BGS Market Growth, by Material, US, 2014-2023
  • Table 64: Trauma Surgery Bone Graft Procedures, by Procedure Type, US, 2013-2023
  • Table 65: Trauma Surgery Bone Graft Units Used, by Material, US, 2013-2023
  • Table 66: Trauma Surgery BGS Market, by Material, US (USD), 2013-2023
  • Table 67: Fresh Fracture Surgeries, by Procedure Type, US, 2013-2023
  • Table 68: Fresh Fracture Surgery Bone Graft Units Used, by Material, US, 2013-2023
  • Table 69: Fresh Fracture Surgery BGS Market, by Material, US (USD), 2013-2023
  • Table 70: Fresh Fracture Surgery BGS Market Growth, by Material, US, 2014-2023
  • Table 71: Nonunion Surgery Bone Graft Units Used, by Material, US, 2013-2023
  • Table 72: Nonunion Surgery BGS Market, by Material, US (USD), 2013-2023
  • Table 73: Nonunion Surgery BGS Market Growth, by Material, US, 2014-2023
  • Table 74: Large-Joint Revision and Reconstruction Bone Graft Procedures, by Product Type, US, 2013-2023
  • Table 75: Large-Joint Revision and Reconstruction Bone Graft Units Used, by Material, US, 2013-2023
  • Table 76: Large-Joint Revision and Reconstruction BGS Market, by Material, US (USD), 2013-2023
  • Table 77: Primary TKAs, by Procedure Type, US, 2013-2023
  • Table 78: Primary TKA Bone Graft Units Used, by Material, US, 2013-2023
  • Table 79: Primary TKA BGS Market, by Material, US (USD), 2013-2023
  • Table 80: Primary TKA BGS Market Growth, by Material, US, 2014-2023
  • Table 81: Knee Revisions, by Procedure Type, US, 2013-2023
  • Table 82: Knee Revision Bone Graft Units Used, by Material, US, 2013-2023
  • Table 83: Knee Revision BGS Market, by Material, US (USD), 2013-2023
  • Table 84: Knee Revision BGS Market Growth, by Material, US, 2014-2023
  • Table 85: Primary THAs, by Procedure Type, US, 2013-2023
  • Table 86: Primary THA Bone Graft Units Used, by Material, US, 2013-2023
  • Table 87: Primary THA BGS Market, by Material, US (USD), 2013-2023
  • Table 88: Primary THA BGS Market Growth, by Material, US, 2014-2023
  • Table 89: Hip Revisions, by Procedure Type, US, 2013-2023
  • Table 90: Hip Revision Bone Graft Units Used, by Material, US, 2013-2023
  • Table 91: Hip Revision BGS Market, by Material, US (USD), 2013-2023
  • Table 92: Hip Revision BGS Market Growth, by Material, US, 2014-2023
  • Table 93: Extremity Surgeries, by Procedure Type, US, 2013-2023
  • Table 94: Extremity Surgery Bone Graft Units Used, by Material, US, 2013-2023
  • Table 95: Extremity Surgery BGS Market, by Material, US (USD), 2013-2023
  • Table 96: Extremity Surgery BGS Market Growth, by Material, US, 2014-2023
  • Table 97: CMF Surgeries, by Procedure Type, US, 2013-2023
  • Table 98: CMF Surgery Bone Graft Units Used, by Material, US, 2013-2023
  • Table 99: CMF Surgery BGS Market, by Material, US (USD), 2013-2023
  • Table 100: CMF Surgery BGS Market Growth, by Material, US, 2014-2023
  • Figure 5: BGS Revenue Market Shares, US, 2014
  • Table 101: BGS Revenue Market Shares, by Material, US, 2014

3. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Figure 6: HA Viscosupplementation Market, by Number of Injections, US (USD), 2013-2023
  • Table 102: HA Viscosupplementation Treatments and Injections, by Number of Injections, US, 2013-2023
  • Table 103: HA Viscosupplementation Market, by Number of Injections, US (USD), 2013-2023
  • Table 104: HA Viscosupplementation Market Growth, by Number of Injections, US, 2014-2023
  • Table 105: HA Viscosupplementation Treatments, by Anatomy, US, 2013-2023
  • Table 106: HA Viscosupplementation Market, by Anatomy, US (USD), 2013-2023
  • Table 107: HA Viscosupplementation Market Growth, by Anatomy, US, 2014-2023
  • Figure 7: HA Viscosupplementation Revenue Market Shares, US, 2014
  • Table 108: HA Viscosupplementation Revenue Market Shares, by Number of Injections, US, 2014

4. MACHINED BONE INTERBODY DEVICE MARKET

  • Figure 8: Machined Bone IBD Market, by Approach, US (USD), 2013-2023
  • Table 109: Machined Bone IBD Fusions, by Approach, US, 2013-2023
  • Table 110: Machined Bone IBD Market, by Approach, US (USD), 2012-2022
  • Table 111: Machined Bone IBD Market Growth, by Approach, US, 2014-2023
  • Figure 9: Machined Bone IBD Revenue Market Shares, US, 2014
  • Table 112: Machined Bone IBD Revenue Market Shares, US, 2014

5. CELL CONCENTRATION SYSTEM MARKET

  • Figure 10: Cell Concentration System Market, by Product Type, US (USD), 2013-2023
  • Table 113: Cell Concentration System Procedures, by Product Type, US, 2013-2023
  • Table 114: Cell Concentration System Procedures, by Procedure Type, US, 2013-2023
  • Table 115: Platelet Concentration Procedures, by Procedure Type, US, 2013-2023
  • Table 116: BMAC Procedures, by Procedure Type, US, 2013-2023
  • Table 117: BMA Procedures, by Procedure Type, US, 2013-2023
  • Table 118: Cell Concentration System Market, by Product Type, US (USD), 2013-2023
  • Table 119: Platelet Concentration System Market, by Product Type, US (USD), 2013-2023
  • Table 120: Platelet Concentration System Market Growth, by Product Type, US, 2014-2023
  • Table 121: BMAC System Market, US (USD), 2013-2023
  • Table 122: BMA System Market, US (USD), 2013-2023
  • Figure 11: Cell Concentration System Revenue Market Shares, US, 2014
  • Table 123: Cell Concentration System Revenue Market Shares, by Product Type, US, 2014

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

  • Table 124: Acronyms and Initialisms

APPENDIX: BIBLIOGRAPHY

Show More
Pricing